Inter‐ and intrafractional dose uncertainty in hypofractionated Gamma Knife radiosurgery

Abstract

The purpose of this study is to evaluate inter‐ and intrafractional dose variations resulting from head position deviations for patients treated with the Extend relocatable frame system utilized in hypofractionated Gamma Knife radiosurgery (GKRS). While previous reports characterized the residual setup and intrafraction uncertainties of the system, the dosimetric consequences have not been investigated. A digital gauge was used to measure the head position of 16 consecutive Extend patients (62 fractions) at the time of simulation, before each fraction, and immediately following each fraction. Vector interfraction (difference between simulation and prefraction positions) and intrafraction (difference between postfraction and prefraction positions) shifts in patient position were calculated. Planned dose distributions were shifted by the offset to determine the time‐of‐treatment dose. Variations in mean and maximum target and organ at risk (OAR) doses as a function of positional shift were evaluated. The mean vector interfraction shift was 0.64 mm (Standard Deviation (SD): 0.25 mm, maximum: 1.17 mm). The mean intrafraction shift was 0.39 mm (SD: 0.25 mm, maximum: 1.44 mm). The mean variation in mean target dose was 0.66% (SD: 1.15%, maximum: 5.77%) for interfraction shifts and 0.26% (SD: 0.34%, maximum: 1.85%) for intrafraction shifts. The mean variation in maximum dose to OARs was 7.15% (SD: 5.73%, maximum: 30.59%) for interfraction shifts and 4.07% (SD: 4.22%, maximum: 17.04%) for intrafraction shifts. Linear fitting of the mean variation in maximum dose to OARs as a function of position yielded dose deviations of 10.58%/mm for interfractional shifts and 7.69%/mm for intrafractional shifts. Positional uncertainties when performing hypofractionated Gamma Knife radiosurgery with the Extend system are small and comparable to frame‐based uncertainties (<1 mm). However, the steep dose gradient characteristics of GKRS mean that the dosimetric consequences of positional uncertainties should be considered as part of treatment planning. These dose uncertainties should be evaluated in the context of tumor response and OAR tolerance for hypofractionated treatment scenarios where any increase in dose may be tempered by the increased protection hypofractionation provides to normal tissue.PACS number(s): 87.52.‐g

Clinical Positioning Accuracy for Multisession Stereotactic Radiotherapy With the Gamma Knife Perfexion

“…Commissioning and quality assurance has been presented, 14 and the dosimetric impact of inter- and intrafractional uncertainties has been studied. 15 Three reports of patient setup uncertainty with small patient numbers, 10 2 and 12, 3 , 4 have produced results that are consistent with our measurement of 0.48 (0.19) mm, taken on 352 consecutive treatments from 84 patients, which is a larger cohort than the combined previously published experiences.…”

8+ Year Performance of the Gamma Knife Perfexion/Icon Patient Positioning System and Possibilities for Preemptive Fault Detection Using Statistical Process Control

“…Placing this focus point at the intended position in the patient with low uncertainty is critical to the success of the procedure 2 . Uncertainty in targeting risks placing the high‐intensity portion of the dose distribution over incorrect anatomy, possibly resulting in a lower than desired dose to the target and a higher than desired dose to nearby normal anatomy 3 …”

Monitoring frequency of intra‐fraction patient motion using the ExacTrac system for LINAC‐based SRS treatments

“…These positioning errors are still too large for SRS treatments, due to irradiating critical organs during the treatment. A study by Kim et al measured the intrafraction shift of 16 patients and found the average to be 0.39 mm, however, this small shift resulted in an average variation in maximum dose to organs at risk (OAR) of 7.15% 6. Image guidance significantly reduces the setup errors, and is essential for accurate delivery of SRS.…”